These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 32065279

  • 21. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.
    Castro A, Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    HLA; 2017 Nov; 90(5):267-275. PubMed ID: 28776960
    [Abstract] [Full Text] [Related]

  • 22. Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study.
    Sakamoto S, Iwasaki K, Tomosugi T, Niemann M, Spierings E, Miwa Y, Horimi K, Takeda A, Goto N, Narumi S, Watarai Y, Kobayashi T.
    Front Immunol; 2020 Nov; 11():2000. PubMed ID: 32973806
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation.
    Islam AK, Sinha N, DeVos JM, Kaleekal TS, Jyothula SS, Teeter LD, Nguyen DTM, Eagar TN, Moore LW, Puppala M, Wong STC, Knight RJ, Frost AE, Graviss EA, Osama Gaber A.
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658512
    [Abstract] [Full Text] [Related]

  • 25. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
    Parajuli S, Aziz F, Blazel J, Muth BL, Garg N, Mohamed M, Rice J, Mezrich JD, Hidalgo LG, Mandelbrot D.
    Transplantation; 2021 Jul 01; 105(7):1548-1555. PubMed ID: 32732618
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A, Van Loon E, Lerut E, Coemans M, Callemeyn J, Daniëls L, Kerkhofs J, Koshy P, Kuypers D, Lamarthée B, Sprangers B, Tinel C, Van Craenenbroeck AH, Van Sandt V, Emonds MP, Naesens M.
    Am J Kidney Dis; 2022 Dec 01; 80(6):718-729.e1. PubMed ID: 35690154
    [Abstract] [Full Text] [Related]

  • 29. Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation.
    Ladowski JM, Mullins H, Romine M, Kloda D, Young C, Hauptfeld-Dolejsek V, Houp J, Locke J.
    Hum Immunol; 2021 Mar 01; 82(3):139-146. PubMed ID: 33390268
    [Abstract] [Full Text] [Related]

  • 30. Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.
    Wiebe C, Pochinco D, Blydt-Hansen TD, Ho J, Birk PE, Karpinski M, Goldberg A, Storsley LJ, Gibson IW, Rush DN, Nickerson PW.
    Am J Transplant; 2013 Dec 01; 13(12):3114-22. PubMed ID: 24164958
    [Abstract] [Full Text] [Related]

  • 31. Which is the best predictor of de novo donor-specific antibodies in a cohort of non-sensitized first kidney transplantation: Antigenic, allelic, epitope, or physiochemical HLA mismatches?
    Delion A, Girerd S, Duarte K, Girerd N, Schikowski J, Kessler M, Frimat L, Aarnink A.
    Clin Transplant; 2019 Apr 01; 33(4):e13508. PubMed ID: 30821002
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
    Lachmann N, Niemann M, Reinke P, Budde K, Schmidt D, Halleck F, Pruß A, Schönemann C, Spierings E, Staeck O.
    Am J Transplant; 2017 Dec 01; 17(12):3076-3086. PubMed ID: 28613392
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation.
    McCaughan JA, Battle RK, Singh SKS, Tikkanen JM, Moayedi Y, Ross HJ, Singer LG, Keshavjee S, Tinckam KJ.
    Am J Transplant; 2018 Dec 01; 18(12):2924-2933. PubMed ID: 29847022
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.